Stay updated on Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.

Latest updates to the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page
- Check2 days agoChange DetectedThe page now shows revision v3.6.3, replacing the previous v3.6.0. This reflects an internal update to the page rendering rather than changes to the trial data.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew user-facing sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header formatting was updated. The recruitment status now shows No longer looking for participants, and the revision tag was updated from Revision: v3.5.5 to Revision: v3.6.0.SummaryDifference0.5%

- Check23 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a system or interface update. It does not alter the study details or data presented.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating a newer version of the page content.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page’s footer release revision/version was updated from **v3.5.2** to **v3.5.3** without any apparent change to the underlying study information.SummaryDifference0.1%

- Check73 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.